tiprankstipranks
Advertisement
Advertisement
Immunovant’s Talent Crunch: How Human Capital Risks Could Derail IMVT-1402 Development Across Six Indications
PremiumCompany AnnouncementsImmunovant’s Talent Crunch: How Human Capital Risks Could Derail IMVT-1402 Development Across Six Indications
2M ago
Immunovant price target raised to $43 from $32 at BofA
Premium
The Fly
Immunovant price target raised to $43 from $32 at BofA
2M ago
Immunovant price target raised to $40 from $35 at H.C. Wainwright
Premium
The Fly
Immunovant price target raised to $40 from $35 at H.C. Wainwright
2M ago
Insiders Dump Shares in Global-e, EyePoint, Immunovant, Nerdy, Argan
PremiumWeekend UpdatesInsiders Dump Shares in Global-e, EyePoint, Immunovant, Nerdy, Argan
3M ago
Immunovant price target raised to $32 from $29 at Goldman Sachs
Premium
The Fly
Immunovant price target raised to $32 from $29 at Goldman Sachs
3M ago
Elbit, Vor, Global-e, Sweetgreen, Immunovant: Insider Shake-Up
Premium
Weekend Updates
Elbit, Vor, Global-e, Sweetgreen, Immunovant: Insider Shake-Up
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100